wolf biotech gmbh
2
3M
1
0.50
- Areas of investment
Summary
The company was established in Europe in Germany. The leading representative office of defined VC is situated in the Starnberg.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the wolf biotech gmbh, startups are often financed by VRD GmbH, WIC, S-Refit. The meaningful sponsors for the fund in investment in the same round are VRD GmbH, Bayern Kapital GmbH, WIC. In the next rounds fund is usually obtained by VRD GmbH, Bayern Kapital GmbH, Bavarian Growth Fund.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Lophius Biosciences Among the most popular fund investment industries, there are Biotechnology, Health Care.
The high activity for fund was in 2016. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (2)
- Health Diagnostics (2)
- Health Care (2)
- Investments by region
-
- Germany (2)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.